• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, March 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Tulane researchers find other layers of immunity in TB/HIV…

Bioengineer.org by Bioengineer.org
January 26, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Gena Chattin

Tulane University researchers found some monkeys whose immune systems are depleted by the simian strain of HIV have a second line of defense against tuberculosis. The discovery could have significant impacts on future vaccines for TB. The research led by study author Deepak Kaushal, Professor of Microbiology and Immunology at the Tulane National Primate Research Center has been published in the Proceedings of the National Academy of Sciences.

People co-infected with Mycobacterium tuberculosis (Mtb) and HIV are up to 20 times more likely than people without HIV to develop active, clinical tuberculosis (TB) over their lifetimes. HIV targets CD4 T cells and researchers believe depletion of those cells, the first layer of immune response, drives up the progression of TB. Currently, most vaccines being developed for TB only target the CD4 arm of immunity.

Kaushal's research team exposed macaques to Mtb and simian immunodeficiency virus (SIV) to replicate human co-infection. They discovered one-third of the animals maintained latent TB despite complete loss of lung CD4 T cells. A study of the lung tissue revealed CD8 cells and B cells both worked to provide immunity against active TB.

Kaushal says future vaccines for tuberculosis should try to elicit immune responses from not only CD4 cells but also CD8 and B cells.

"This monkey model is the closest we can get to the human environment of these two diseases," Kaushal says. "This discovery is important because it lays out the whole gambit of the different immune functions that are required for an optimum response."

The research revealed a subpopulation of macaques better able to fight TB and HIV co-infection, and Kaushal says it can be presumed this subpopulation of humans also exists. He believes the difference is genetic.

Kaushal hopes to continue the research and move on to the next step of developing a vaccine. "Our job now is to find out the mechanism of why these differences occurred," Kaushal says.

###

Media Contact

Carolyn Scofield
[email protected]
504-247-1443
@TulaneNews

http://www.tulane.edu

Share12Tweet7Share2ShareShareShare1

Related Posts

Prioritize Intensity Over Duration: How Harder Exercise Lowers Disease and Mortality Risks

March 30, 2026
Squirrels Scale Greater Heights to Access Superior Snacks

Squirrels Scale Greater Heights to Access Superior Snacks

March 30, 2026

New Zebrafish Study Sheds Light on Why Haploid Fish Embryos Often Fail to Fully Develop

March 30, 2026

Boron Neutron Capture Therapy: A Breakthrough in Cancer Treatment

March 29, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1005 shares
    Share 397 Tweet 248
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Advancements in EV Battery Technology to Surpass Climate Change-Induced Degradation

    45 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Prioritize Intensity Over Duration: How Harder Exercise Lowers Disease and Mortality Risks

Squirrels Scale Greater Heights to Access Superior Snacks

New Zebrafish Study Sheds Light on Why Haploid Fish Embryos Often Fail to Fully Develop

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.